Mankind Pharma Ltd. Financials: Quarterly Results
Revenue
3557.22
Cr.
PAT
556.43
Cr.
EBITDA
821.09
Cr.
Mankind Pharma Ltd. Q4FY26 Financial Metrics
| Indicator | Mar-26 | Dec-25 | Sep-25 | Jun-25 | Mar-25 |
|---|---|---|---|---|---|
| Net Sales/Income from operations (Cr.) | 3442.93 | 3567.20 | 3697.16 | 3570.35 | 3079.37 |
| Total Income From Operations (Cr.) | 3442.93 | 3567.20 | 3697.16 | 3570.35 | 3079.37 |
| P/L Before Interest, Excpt. Items & Tax (Cr.) | 821.09 | 769.58 | 791.38 | 707.97 | 703.65 |
| P/L Before Exceptional Items & Tax (Cr.) | 679.34 | 612.38 | 621.70 | 537.32 | 513.11 |
| P/L After Tax from Ordinary Activities (Cr.) | 556.43 | 410.67 | 517.86 | 441.45 | 426.67 |
| Net Profit/Loss For the Period (Cr.) | 556.43 | 410.67 | 517.86 | 441.45 | 422.33 |
| Basic EPS | 13.44 | 9.90 | 12.39 | 10.62 | 10.20 |
FAQs
Mankind Pharma Ltd. announced its quarterly results for Q4 FY2026 on May 20, 2026.
In Q4 FY2026, Mankind Pharma Ltd. are as follows:
Revenue: ₹3557.22 crore
Net Profit: ₹556.43 crore.
For Q4 FY2026, Mankind Pharma Ltd. posted ₹3557.22 crore in revenue and ₹556.43 crore in net profit.
Past quarterly results for Mankind Pharma Ltd. can be found on their official Investor Relations page, which includes detailed reports and financial performance summaries.